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Abstract
Background The aim of the present study was to compare
the pain levels resulting from the use of a silicone ring
tourniquet (SRT) to those resulting from the use of a classic
pneumatic cuff tourniquet (PT) in patients undergoing
carpal tunnel release under local anesthesia.
Materials and methods Fifty patients that underwent
carpal tunnel release under local anesthesia were random-
ized using the technique of stratified randomization by
minimization. A forearm tourniquet was applied: a standard
PT was used in 25 patients, and an SRT was used in the other
25 patients (the model of SRT used was selected according
to the standard systolic blood pressure). Patient demo-
graphics and complications were recorded. Pain levels were
assessed with the visual analogue scale and were recorded
(a) just after tourniquet application, (b) 5 min after tourni-
quet application, and (c) just before tourniquet removal.
Results There was no statistical significant difference in
patient demographics between the two groups. The mean
tourniquet time was similar for both groups (p = 1.000). The
difference between the mean final pain level and the mean
initial pain level was statistically significant for the SRT
group (p = 0.010) and highly statistically significant for the
PT group (p \ 0.001). The mean final pain level for the PT
group was higher than that for the SRT group (p = 0.043).
Conclusions According to the findings of this study, in
patients who underwent carpal tunnel release under local
anesthesia, the pain levels at the end of the operation and
those just before the removal of the tourniquet were higher
in the PT group than in the SRT group of patients.
Keywords Tourniquet  Pneumatic tourniquet 
Silicon ring tourniquet  Tourniquet pain
Introduction
Tourniquet devices are commonly used in orthopedic
procedures in order to provide a bloodless operating field
during surgical procedures involving the extremities.
Pneumatic tourniquets (PTs) are preferred by most sur-
geons, and modern pneumatic tourniquets are designed to
minimize the incidence of complications [1]. Nevertheless,
complications do still occur, and a recent study showed that
the incidence of tourniquet complications is still at least as
high as that estimated in the 1970s [2].
However, a new device known as a silicon ring tourni-
quet (SRT) was introduced into clinical practice relatively
recently [3–6]. This a novel device (marketed as the
S-MART or HemaClear, OHK Medical Devices, Haifa,
Israel) consists of a silicone ring wrapped within an elastic
sleeve (stockinet) and two straps attached to pull handles,
and is designed for exsanguination and occlusion of the
blood flow to the limb.
The entire device is sterile and comes in different sizes:
(a) a small size for pediatric use; (b) a medium size for an
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upper limb (circumference of the limb at the occlusion site
24–40 cm); (c) a large size for the leg (circumference of
the limb at the occlusion site 30–55 cm); and (d) an extra-
large size for the leg (circumference of the limb at the
occlusion site 50–90 cm and systolic blood pressure
B160 mmHg). There are three tension models (systolic
blood pressure B130 mmHg, \160 mmHg, \190 mmHg)
for the medium and large sizes, and the appropriate model
is selected for each patient according to the systolic blood
pressure measured in the operating room before the
placement of the device.
This device has been compared to the pneumatic tour-
niquet in healthy volunteers [7, 8], and in a clinical study of
patients that underwent upper extremity operations [4].
The aim of this randomized prospective study was to com-
pare the pain levels resulting from the use of the classic pneu-
matic tourniquet to the pain levels resulting from the use of this
new device in patients undergoing carpal tunnel release.
Materials and methods
Study design
Patients who were scheduled for carpal tunnel release
under local anesthesia and had no previous fracture or
operation in the affected limb as well as no history of
anemia, malignancy, or neurological disorder were inclu-
ded in this study. All of the patients gave their informed
consent prior to being included into the study. The study
was authorized by the local ethical committee (hospital
ethics committee approval: UGHA 157/2-7-2010), and was
performed in accordance with the ethical standards of the
1964 Declaration of Helsinki, as revised in 2000.
Fifty patients were randomized using the technique of
stratified randomization by minimization [9, 10]. The
patients were assigned to a treatment group (SRT or PT)
according to a stratified and blocked randomization
method. The randomization was based on four parameters:
age (30–39, 40–49, 50–59 years), gender (male, female),
body mass index (BMI) (less than 25, 25–29.9, more than
30), and whether the patient was a smoker (yes or no). Each
patient’s age, gender, body mass index (BMI), smoking
status, occupation, other illnesses, medications, and domi-
nant hand were recorded. Patients were followed up for any
complications related to tourniquet use or to the operation
up to 30 days postoperatively.
Tourniquet types
A standard pneumatic tourniquet (PT) with an 8 cm wide
cuff and the appropriate SRT model (selected according to
the standard systolic pressure) were used.
Procedure
The procedure was explained to all participants. They were
also instructed how to use the visual analogue scale for
discomfort/pain (0 = no discomfort/pain; 10 = the worst
pain) [11]. The patients were placed in a comfortable,
supine position out of sight of clocks or monitoring
equipment. The systolic and diastolic blood pressures and
the pulse rate were monitored using a noninvasive monitor,
and the cuff/cables were applied to the unaffected upper
limb. After a 10 min period to allow the values of the
recorded variables to stabilize, the systolic pressure was
measured and used as the standard.
A forearm tourniquet was used in all patients. A PT with
an 8 cm wide cuff was applied over two layers of smoothly
applied cast padding. The limb was elevated for 3 min
before tourniquet inflation. The PT inflation pressure was
100 mm Hg above the standard systolic blood pressure.
The appropriate SRT model was selected according to the
standard systolic blood pressure and applied as recom-
mended by the manufacturer.
The VAS levels for pain were recorded (a) just after
tourniquet application (initial pain, T0), (b) 5 min after the
tourniquet application (T5), and (c) just before the tourni-
quet removal (final pain, Tfinal).
The surgical technique employed was the same in all
patients. Open carpal tunnel release was performed under
local anesthesia with ropivacaine. A curved skin incision
was made ulnar to and parallel to the thenar crease, fol-
lowed by an inline incision of the subcutaneous tissue and
the palmar aponeurosis. The distal end of the transverse
carpal ligament was identified and the ligament was
incised. The flexor tenosynovium was inspected before the
skin closure with 3-0 nylon suture. A compressive dressing
was applied and the hand was kept elevated for two days,
during which time the patients were instructed to perform
active finger movements. Subsequently, a smaller dressing
was applied and the patient was encouraged to gradually
resume normal use of the hand. The sutures were removed
after 12–14 days.
Statistical analysis
Statistical analysis of the data was performed using the
Statistical Package for the Social Sciences (SPSS), version
19.0 (SPSS, Inc., Chicago, IL, USA). All quantitative
variables were expressed as the mean ± SD, while quali-
tative variables were expressed as frequencies (and per-
centages). The normality of the quantitative variables was
tested with the Kolmogorov–Smirnov test. The v2 test and
Student’s t test were used to assess differences in demo-
graphic characteristics between the two groups of patients.
Between-group differences in VAS score were assessed by
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Student’s t test, while within-group differences were
examined by one-way repeated-measures ANOVA (rmA-
NOVA); post hoc analysis was performed using Bonfer-
roni’s correction. The interaction between the type of the
tourniquet and the change in VAS score over time was
established by performing two-way analysis of variance.
All tests were two-tailed and statistical significance was
considered for p values of less than 0.05.
Results
Patients
There were no complications related to the tourniquet in
either group, or wound infections. There were no statisti-
cally significant differences in gender (p = 0.713), age
(p = 0.658), BMI (p = 0.712), smoking status (p =
1.000), occupation (p = 0.758), other illness (p = 0.569),
medication (p = 0.569), or the dominant hand (p = 0.208)
between the two groups of patients (Table 1).
Tourniquet time
The mean tourniquet time was identical in the two groups
(p = 1.000): 10.20 ± 2.78 min (median time, 10 min) for
SRT and 10.20 ± 3.58 min (median time, 10 min) for PT.
Pain levels
The VAS score for pain at the site of tourniquet application
is shown for each device in Table 1 and Fig. 1. Since the
Kolmogorov–Smirnov test did not show any significant
deviation from the normal distribution, the VAS score was
expressed as the mean ± SD.
One-way repeated-measures ANOVA showed statisti-
cally significant changes in the VAS score over time (SRT:
F2,48 = 6.030, p = 0.005; PT: F2,48 = 26.791, p \ 0.001).
Post hoc analysis, using Bonferroni’s adjustment for the
number of comparisons, was then performed: SRT appli-
cation produced a gradual elevation of the VAS score from
one measurement to the next by 13.3 and 11.7 %, respec-
tively, but none of these changes reached statistical sig-
nificance (p = 0.324 and p = 0.185, respectively).
Overall, SRT application resulted in a statistically signifi-
cant elevation of the pain score by 26.5 % (p = 0.010)
compared to the initial pain score (from T0 to Tfinal). In the
PT group, an initial nonsignificant (p = 0.195) elevation of
the VAS score by 24.4 % (from T0 to T5) was followed by a
statistically significant elevation of the VAS score by
51.5 % (p \ 0.001) (from T5 to Tfinal). Overall, PT appli-
cation produced a highly significant elevation of the pain
score by 88.5 % (p \ 0.001) compared to the initial pain
score (from T0 to Tfinal).
The time courses for the pain experienced by the two
groups were compared via two-way mixed ANOVA. This
analysis revealed a statistically significant interaction
between the type of the tourniquet and the change in VAS
score over time (F2,48 = 7.189, p = 0.001). In this regard,
Table 1 Patient demographics and pain scores (VAS)
SRT PT p value
N 25 25
Gender male [no (%)] 5 (20.0) 4 (16.0) 0.713
Age (years;
mean ± SD)
54.28 ± 11.17 55.56 ± 9.06 0.658
BMI (mean ± SD) 29.08 ± 5.35 29.57 ± 3.89 0.712
Smoking status [no (%)] 7 (28.0) 7 (28.0) 1.000
Manual work (no %) 18 (72.0) 17 (68.0) 0.758
Other illness [no (%)] 13 (52.0) 15 (60.0) 0.569
Medication [no (%)] 13 (52.0) 15 (60.0) 0.569
Dominant hand right [no
(%)]
20 (80.0) 16 (64.0) 0.208
Tourniquet time (min;
mean ± SD)
10.20 ± 2.78 10.20 ± 3.58 1.000
VAS score (mean ± SE)
T0 3.92 ± 2.12 3.12 ± 2.05 0.181
T5 4.44 ± 1.80 3.88 ± 1.92 0.294
Tfinal 4.96 ± 1.65 5.88 ± 1.48 0.043
Change in VAS score















SRT silicone ring tourniquet, PT pneumatic tourniquet, BMI bone
mass index, VAS visual analogue scale
T0 pain level after tourniquet application, T5 pain level 5 min after
tourniquet application, Tfinal pain level just before tourniquet removal
Fig. 1 Mean pain scores over time. SRT silicone ring tourniquet, PT
pneumatic tourniquet
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although the initial elevation of the VAS score was similar
for the two groups (13.3 % in SRT vs. 24.4 % in PT,
p = 0.634), the pain increased more dramatically in the PT
than in the SRT group from the second measurement until
tourniquet removal (11.7 % in SRT vs. 51.5 % in PT,
p = 0.002). In addition, the increase in the pain score from
tourniquet application until removal was greater in the PT
than in the SRT group (26.5 % in SRT vs. 88.5 % in PT,
p = 0.002).
A comparison of the post-application VAS scores of the
two groups of patients at each measurement showed that
there was: (1) no statistically significant difference between
the PT and SRT groups just after tourniquet application
(p = 0.181) and 5 min after this application (p = 0.294);
(2) a significantly higher VAS score for the PT than for the
SRT group just before tourniquet removal (p = 0.043).
Discussion
According to the findings of this study, patients that
underwent carpal tunnel release under local anesthesia and
with the use of a forearm pneumatic tourniquet experienced
more pain at the end of the procedure compared to patients
for whom the silicone ring tourniquet was used. The pain
levels just after the application of the tourniquet were
higher in the SRT group and remained higher 5 min later
when compared to the PT group. After that, the pain levels
in the SRT group continued to gradually increase in the
same manner as they did during the first 5 min. However,
for the PT group, a more rapid increase in pain levels was
observed, and the mean pain levels in the PT group had
become higher than those in the SRT group by about
6–7 min after the application of the tourniquet . These
fluctuations in pain levels are similar to those seen in a
recently reported study of healthy volunteers [7].
A forearm tourniquet was used in our study because,
according to previous studies, a forearm tourniquet is tol-
erated for longer than an upper arm tourniquet [8, 12].
According to previously published studies [3–6], the
SRT has several advantages: it is easily applied (thus
decreasing the time and effort required for tourniquet
application); it is sterile and can be applied intraoperatively
(saving tourniquet time); no additional step for limb
exsanguination is required; and it covers a narrow area of
the limb. On the other hand, the pressure applied by the
SRT is fixed (cannot be adjusted), and the SRT cannot
entirely replace the PT since it cannot be used in very
obese patients due to limitations on the limb circumfer-
ence. Furthermore, the SRT is disposable, so there is a
direct cost. On the other hand, there is an indirect cost for
PTs. The device requires regular maintenance, repairs, and
replacements, as well as routine checking, daily calibration
checks of all valves and gauges, intraoperative monitoring
of tourniquet function at frequent intervals, and rigorous
monthly performance-assurance tests [1].
Two recently reported studies of healthy volunteers
showed that the SRT performs similarly to the classic PT in
terms of tolerance time [7], and may be more comfortable
than the PT when used on the upper arm [8].
The etiology and the neural pathways of tourniquet pain
seem to be multifactorial [13]. The pressure applied by the
tourniquet is certainly one of the responsible factors.
Narrow cuffs require a higher arterial flow occlusion
pressure [14, 15], and this theoretically increases the
chance of pressure-related complications. Furthermore,
using a non-pneumatic tourniquet for extended periods
may increase the incidence of tourniquet-related adverse
events. Nevertheless, such complications have not been
reported in published clinical series, where the SRT was
used for up to 1.5–2 h [3–6].
On the other hand, a study of human volunteers showed
that narrow cuffs resulted in less pain and were tolerated
for a longer time than wider cuffs [16] and, more recently,
nerve conduction studies showed that wider cuffs result in
more severe nerve changes than narrow cuffs inflated to the
same pressure and used for the same period of time [17].
These findings may explain the results of our study.
In conclusion, according to the findings of this study, in
patients who underwent carpal tunnel release under local
anesthesia, the pain levels at the end of the operation and
those just before the removal of the tourniquet were higher
in the PT group than in the SRT group of patients.
Therefore, it seems that SRT may be advantageous com-
pared to the classic pneumatic tourniquet from a tourniquet
pain perspective in hand operations performed under local
anesthesia, such as carpal tunnel release.
Conflict of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Wakai A, Winter DC, Street JT, Redmond PH (2001) Pneumatic
tourniquets in extremity surgery. J Am Acad Orthop Surg
9:345–351
2. Odinsson A, Finsen V (2006) Tourniquet use and its complica-
tions in Norway. J Bone Joint Surg (Br) 88:1090–1092
3. Boiko M, Roffman M (2004) Evaluation of a novel tourniquet
device for bloodless surgery of the hand. J Hand Surg (Br)
29:185–187
4. Orbay H, Unlu¨ RE, Kerem M, Senso¨z O (2006) Clinical expe-
riences with a new tourniquet device. Ann Plast Surg 56:618–621
134 J Orthopaed Traumatol (2013) 14:131–135
123
5. Eidelman M, Katzman A, Bialik V (2006) A novel elastic
exsanguination tourniquet as an alternative to the pneumatic cuff
in pediatric orthopedic limb surgery. J Pediatr Orthop B
15:379–384
6. Norman D, Greenfield I, Ghrayeb N, Peled E, Dayan L (2009)
Use of a new exsanguination tourniquet in internal fixation of
distal radius fractures. Tech Hand Up Extrem Surg 13:173–175
7. Drosos GI, Stavropoulos NI, Kazakos K, Tripsianis G, Ververidis
A, Verettas DA (2001) Silicone ring versus pneumatic cuff
tourniquet: a comparative quantitative study in healthy individ-
uals. Arch Orthop Trauma Surg 131:447–454
8. Mohan A, Baskaradas A, Solan M, Magnussen P (2011) Pain and
paraesthesia produced by silicone ring and pneumatic tourni-
quets. J Hand Surg Eur 36:215–218
9. Taves DR (1974) Minimization: a new method of assigning
patients to treatment and control groups. Clin Pharmacol Ther
15:443–453
10. Pocock SJ, Simon R (1975) Sequential treatment assignment with
balancing for prognostic factors in the controlled clinical trial.
Biometrics 31:103–115
11. Chapman CR, Casey KL, Dubner R, Foley KM, Gracely RH,
Reading AE (1985) Pain measurement: an overview. Pain
22:1–31
12. Maury AC, Roy WS (2002) A prospective, randomized, con-
trolled trial of forearm versus upper arm tourniquet tolerance.
J Hand Surg (Br) 27:359–360
13. Estebe JP, Le Naoures A, Chemaly L, Ecoffey C (2000) Tour-
niquet pain in a volunteer study: effect of changes in cuff width
and pressure. Anaesthesia 55:21–26
14. Pedowitz RA, Gershuni DH, Botte MJ, Kuiper S, Rydevik BL,
Hargens AR (1993) The use of lower tourniquet inflation pres-
sures in extremity surgery facilitated curved and wide tourniquets
and an integrated cuff inflation system. Clin Orthop Relat Res
287:237–244
15. Graham B, Breault MJ, McEwen JA, McGraw RW (1993)
Occlusion of arterial flow in the extremities at subsystolic pres-
sures through the use of wide tourniquet cuffs. Clin Orthop Relat
Res 286:257–261
16. Hagenouw RR, Bridenbaugh PO, van Egmond J, Stuebing R
(1986) Tourniquet pain: a volunteer study. Anesth Analg 65:
1175–1180
17. Mittal P, Shenoy S, Sandhu JS (2008) Effect of different cuff
widths on the motor nerve conduction of the median nerve: an
experimental study. J Orthop Surg 3:1
J Orthopaed Traumatol (2013) 14:131–135 135
123
